Skip to Content
Emily R. Winslow, MD, FACS

Contact Dr. Winslow

E-mail:
winslow@surgery.wisc.edu

Phone:
(608) 262-2025

Mail:
600 Highland Avenue
BX7375 CLINICAL SCIENCE CNTR
Madison, WI 53792-7375

Fax:
(608) 252-0913

Emily R. Winslow, MD, FACS

Assistant Professor
Section of GI Surgical Oncology
Division of General Surgery

Education

  • MD, Harvard Medical School, Boston, MA, 1999
  • Residency in Internal Medicine, Boston University School of Medicine, Boston, MA, 2000
  • Residency in General Surgery, Washington University School of Medicine, St. Louis, MO, 2000-2006
  • Fellowship in Hepatopancreaticobiliary Surgery, Washington University School of Medicine, St. Louis, MO, 2007
  • Fellowship in Transplant Surgery, Northwestern Memorial Hospital, Chicago, IL, 2009

Clinical Specialties

Dr. Winslow specializes in benign and malignant disease in the liver, bile duct, and pancreas. She performs both laparoscopic and open liver and pancreas surgery. She has specific clinical interest in patients with pancreatic cancer, cholangiocarcinoma, metatstatic colorectal cancer, and bile duct injuries. She is certified by the American Board of Surgery.

Dr. Winslow provides a wide range of services including Beger Procedure, Bile Duct Resection, Caudate Resection, Cryoablation, Cyst Fenestration (Unroof Liver Cyst), Frey Procedure, Gastrectomy - Partial or Total, Hemihepatectomy (Hepatectomy), Laparoscopic and Robotic Gastrectomy, Laparoscopic Liver Resection, Laparoscopic Pancreatectomy, Liver Resection, Liver Tumor Ablations, Obstructed Pancreatic Duct Drainage (Peustow Procedure), Pancreatic Head Resection, Pancreaticoduodenectomy, Pancreatic Pseudocysts Drainage, Pancreatic Resections, Radical Cholecystectomy, Radiofrequency Ablation, (show all).

Research Interests

Dr. Winslow conducts clinical research in patients with pancreatic cancer and neuroendocrine tumors. She also is interested in outcomes studies in patients with hepatobiliary malignancies. She is currently pursuing a master’s degree in Clinical Investigation at the Institute for Clinical and Translational Research, with the goal of developing a research program focused on patient-centered outcomes in surgical oncology.

Recent Publications
  • Does Postoperative Drain Amylase Predict Pancreatic Fistula after Pancreatectomy?
    Israel JS, Rettammel RJ, Leverson GE, Hanks LR, Cho CS, Winslow ER, Weber SM
    J. Am. Coll. Surg. 2014 Feb 18.
    [PubMed ID: 24680573]
    More Information
  • Impact of cardiac comorbidity on early outcomes after pancreatic resection.
    Ronnekleiv-Kelly SM, Greenblatt DY, Lin CP, Kelly KJ, Cho CS, Winslow ER, Weber SM
    J. Gastrointest. Surg. 2014 Mar; 18(3):512-22.
    [PubMed ID: 24277570]
    More Information
  • Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?
    Kelly KJ, Winslow E, Kooby D, Lad NL, Parikh AA, Scoggins CR, Ahmad S, Martin RC, Maithel SK, Kim HJ, Merchant NB, Cho CS, Weber SM
    J. Gastrointest. Surg. 2013 Jul; 17(7):1209-17; discussion 1217.
    [PubMed ID: 23620151]
    More Information
  • Preoperative classification of pancreatic cystic neoplasms: the clinical significance of diagnostic inaccuracy.
    Cho CS, Russ AJ, Loeffler AG, Rettammel RJ, Oudheusden G, Winslow ER, Weber SM
    Ann. Surg. Oncol. 2013 Sep; 20(9):3112-9.
    [PubMed ID: 23595223]
    More Information
  • Laparoscopic resection of the liver for cancer.
    Winslow E, Hawkins WG
    Surg. Oncol. Clin. N. Am. 2013 Jan; 22(1):75-89, vi.
    [PubMed ID: 23158086]
    More Information

webmaster@surgery.wisc.edu Copyright © 2014 The Board of Regents of the University of Wisconsin System